OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC)

Taofeek K. Owonikoko, Kristiaan Nackaerts, Tibor Csőszi, Gyula Ostoros, Christina S. Baik, Claudio Dansky Ullmann, Erin Zagadailov, Emily Sheldon‐Waniga, Dirk Huebner, E. Jane Leonard,

Journal of Thoracic Oncology · 2017 · 21 citations · 0 references

Concepts